Webb23 feb. 2024 · Company. Philogen SpA is an Italy-based company, operating in the biotechnology sector. The Company develops products and technologies for the … Webb11 apr. 2024 · Philogen : tra 16 e 19/8 acquistate 716 azioni. 2024. Philogen : allo 0,3862% del capitale dopo ultimi buyback. 2024. Philogen S.p.A. Announces Enrolment of 214 Patients in the Nidlegy Phase III European C..
Philogen se développe en 2024, les revenus s
Webb23 mars 2024 · Philogen SpA entwickelte eine patentierte Technologie, das Iterative Colony Filter Screening, für die Isolierung von monoklonalen Antikörpern, die weder Immunisierung noch Phage Display erfordert. Die Tochtergesellschaften des Unternehmens sind Philotec, Philomed und Philochem. Webb11 apr. 2024 · Tutte le notizie su PHILOGEN S.P.A. 17:36: Philogen ha acquistato 3.481 azioni ordinarie proprie: AN. 16:28: Philogen S P A: 11 aprile 2024 – Aggiornamento sul programma di acquisto di azioni .. PU. 05/04: Philogen S P A: Relazione annuale sul Governo Societario e gli Assetti Proprietari &ndash.. PU. great river medical center map
Philogen S.p.A. Reports Earnings Results for the Full Year Ended ...
Webb28 mars 2024 · (Alliance News) - Philogen Spa a annoncé mardi avoir vu sa perte nette pour 2024 se réduire considérablement, à 5,4 millions d'euros, contre une perte de 15,7 millions d'euros l'année... WebbPhilogen is a Swiss-Italian biotechnology company, founded in 1996 and listed on the Italian Stock Exchange, with a mission to innovate the treatment of cancer and other … About us - Philogen is a Swiss-Italian biotechnology company Our Science - Philogen is a Swiss-Italian biotechnology company + Radiation – Non-Small Cell Lung Cancer – – – – Dodekin. Preclinical Philogen kindly invites you to attend a virtual briefing for analysts on 29 March … Work with us - Philogen is a Swiss-Italian biotechnology company Philogen S.p.A. publishes its regulatory disclosures through the SDIR-NIS circuit … The Board of Directors has appointed a Control, Risk and Sustainability … Small Molecule Therapeutics. Low molecular weight compounds can be … WebbPhilogen Group. Founded in 1996, Philogen is an Italian-Swiss biotechnology company engaged in the discovery and development of biopharmaceutical products for the … floppy part of the ear